Skip Navigation

Pharmacy Residency Program

  • pharmacy clean room

    The mission of Dana-Farber Cancer Institute is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related disease.

    The Pharmacy department maintains programs and practices to ensure safe, optimal, and cost effective drug therapy for Dana-Farber patients, while also supporting patient and provider drug education and patient care-oriented research.

  • About the Pharmacy Residency Program

    Dana-Farber Cancer Institute is proud to offer oncology pharmacy residency positions in two ASHP-accredited Post Graduate Year 2 (PGY-2) practice specialties:

    • Hematology/Oncology Pharmacy Residency(Hem/Onc)
    • Pain Management/Palliative Care Pharmacy Residency (PMPC)

    These positions are designed to provide the resident with opportunities to develop clinical competence in oncology pharmacy practice. Residents are exposed to a multitude of experiences related to cancer care, involving both inpatient care and ambulatory-related experiences.

    Pharmacy resident benefits

    Pharmacy residents will receive a competitive stipend for the PGY-2 residency year. Other benefits include, but are not limited to, medical and dental coverage, and MBTA discount passes. In addition, pharmacy residents will be invited to attend professional conferences, including:

    Holidays

    New Year’s Day, Martin Luther King Day, President’s Day, Memorial Day, Independence Day, Labor Day, Columbus Day, Thanksgiving Day, and Christmas Day are all observed holidays.

    Vacation days

    Residents are entitled to 10 days of vacation. Vacation days are to be approved by the residency director and sufficient notice given.

  • Hematology/Oncology Pharmacy Residency (Hem/Onc)

    Residents in the Hematology/Oncology Pharmacy Residency will gain experience in the following areas of practice:

    • Adult ambulatory oncology
    • Inpatient medical and hematologic oncology
    • Inpatient stem cell transplant
    • Palliative care
    • Pediatric oncology
    • Medication safety
    • Investigational drug services
    • Grand rounds, tumor board, and other oncology-related lectures

    Through these educational experiences, residents will:

    • Demonstrate development as a role model for clinical pharmacists in the oncology setting.
    • Develop various teaching styles for application in a variety of settings, including experiential education, small group teaching, and group lecture.
    • Collaborate with clinical pharmacy staff to provide educational resources for patients and practitioners.
    • Develop skills in pharmacy administration, disease state management, drug information, synthesis and analysis of clinical information, and development of clinical care plans.
    • Refine communication and time management skills.
    • Develop, implement, and analyze data of a year-long, publishable research project.
    • Incorporate self-directed learning and personal development through self-reflection, evaluation, and feedback.

    Dana-Farber’s PGY-2 Hematology/Oncology Pharmacy Residency gives residents many opportunities to co-precept and lecture students at the affiliated schools of pharmacy. The residency is primarily affiliated with two schools of pharmacy, including Northeastern School of Pharmacy and Massachusetts College of Pharmacy and Health Sciences University-Boston.

    Research projects

    Research projects will be determined according to the resident's interest and departmental needs. The resident will be required to complete one project to be presented at a national meeting, such as at HOPA (Hematology/Oncology Pharmacy Association) or AAHPM (American Academy of Hospice and Palliative Medicine).

    Examples of past resident research projects include:

    • Evaluation of off-label oral chemotherapy: A pilot study
    • Off-label use of chemotherapy with limited evidence: An assessment of efficacy and safety
    • Characterization and assessment of anti-cancer therapy used to treat elderly patients with gynecologic malignancies
    • Characteristics of hematopoietic stem cell transplant patients who fall
    • Pharmacist-managed counseling for patients who are discharged after hematopoietic stem cell transplant

    Hematology/Oncology residency rotations

    The resident will spend approximately ten months completing core rotations, and is allotted two months for elective experiences and research:

    Core clinical rotations

    • Ambulatory oncology
    • Orientation and training
    • Medical oncology
    • Hematologic oncology
    • Palliative care unit
    • Stem cell transplant
    • Pediatric oncology
    • Investigational drug service

    Longitudinal experiences

    • Medication safety
    • Pharmacy administration
    • Drug information projects
    • Weekly topic discussions
    • Formulary evaluations
    • Drug use evaluations
    • Resident teaching program, if not completed during PGY-1 year
    • Teaching responsibilities at area schools of pharmacy
    • Formal and informal education of colleagues in nursing, pharmacy, and medicine

    Elective opportunities

    • Infectious disease
    • Anticoagulation
    • Critical care
    • Hospice
    • Women's oncology
    • Benign hematology
    • Repeat core
  • Pain Management/Palliative Care Pharmacy Residency (PMPC)

    The Dana-Farber Cancer Institute PGY-2 Pain Management and Palliative Care Pharmacy Residency is designed to provide the resident with opportunities to develop clinical competence in pain management and palliative care in various settings.

    The PGY-2 Pain Management and Palliative Care Pharmacy resident will gain experience in the following areas of practice: inpatient and outpatient palliative care, hospice, inpatient and outpatient specialized pain management, and pain management in the primary care setting. Primary rotation sites include: Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and MCPHS University.

    Didactic and experiential learning is enhanced through the Harvard Interprofessional Palliative Care Fellowship Program, which provides the only opportunity nationally for a pharmacy resident to join a fellowship with medical, nursing, and social work fellows in both adult and pediatric palliative care. The pharmacy resident is fully integrated into this fellowship program, which offers didactic and experiential learning geared toward the health care professional working with an interdisciplinary team.

    Throughout these experiences a resident completing the program will be able to:

    • Demonstrate development as a role model for clinical pharmacists in the pain management and palliative care setting.
    • Develop various teaching styles and approaches for application in a variety of settings, including experiential education, small group teaching, and group lecture.
    • Collaborate with clinical pharmacy staff to provide educational resources for patients and practitioners.
    • Develop skills in the areas of pharmacy administration, disease state management, drug information, synthesis and analysis of clinical information, and development of clinical care plans.
    • Refine communication and time management skills.
    • Develop, implement and analyze data of a yearlong, publishable research project.
    • Incorporate self-directed learning and personal development through self-reflection, evaluation, and feedback.

    Applicants must expect to complete an ASHP-accredited PGY-1 pharmacy residency and be eligible for licensure in the state of Massachusetts. Application requirements: Standard PhORCAS application.

    Pain Management/Palliative Care residency rotations

    The resident will spend approximately nine months completing core rotations, and is allotted three months for elective experiences and research:

    Core clinical rotations

    • Inpatient Palliative Care Unit
    • Home-based hospice
    • Inpatient Palliative Care Consult Team
    • Ambulatory pain management

    Longitudinal experiences

    • Outpatient Palliative Care Clinic
    • Harvard Interprofessional Palliative Care Fellowship
    • Research
    • Academia
    • Outpatient Pharmacy Department staffing

    Elective opportunities

    • Pediatric Advanced Care Team (pediatric palliative care)
    • Psycho-oncology
    • Heart Failure Service
    • Integrative therapies
    • Massachusetts General Hospital palliative care
    • Pain Addiction Service
    • Post-operative pain management
    • Repeat of core rotation, depending on need/interest
    • Other opportunities may be available upon request
  • Preceptors

    Residency Director (Hem/Onc and PMPC)

    Bridget Fowler Scullion, PharmD, BCOP
    Clinical Pharmacy Manager
    Education: St. Louis College of Pharmacy
    PGY-2 Training: University of Maryland, School of Pharmacy, Baltimore, MD

    Administration (Hem/Onc)

    Sylvia B. Bartel, RPh, MHP
    Vice President of Pharmacy Services
    Education: University of Wisconsin, Madison, WI
    PGY-1 Training: National Institutes of Health, Clinical Center, Bethesda, MD

    Ambulatory Oncology (Hem/Onc)

    Christy S. Harris, PharmD, BCPS, BCOP
    Associate Professor, MCPHS University, Clinical Pharmacy Specialist
    Education: University of Tennessee Health Sciences, Memphis, TN
    PGY-1 Training: University of Tennessee Medical Center, Knoxville, TN
    PGY-2 Training: Medical University of South Carolina, Charleston, SC

    Ambulatory Pain Management (PMPC)

    Michele Matthews, PharmD, CPE, BCACP
    Associate Professor of Pharmacy Practice, MCPHS University
    Education: Massachusetts College of Pharmacy and Health Sciences, Boston, MA
    PGY-1 Training: Robert Wood Johnson Hospital, New Brunswick, NJ

    Bone Marrow Transplant/Hematology Malignancies (Hem/Onc)

    Anne McDonnell, PharmD, BCOP
    Inpatient Clinical Pharmacy Specialist
    BS: MCPHS University, Boston
    PharmD: University of Arkansas for Medical Sciences
    PGY-1 Training: New York Presbyterian Hospital, New York, NY
    PGY-2 Training: Medical University of South Carolina, Charleston, SC

    Hospice (PMPC)

    James Krasnow, BS, MS, RPH
    Consultant Pharmacist, Visiting Nurses Association of Boston-Hospice
    BSPharm, Northeastern University, Boston, MA
    Masters,Tufts University, Pain Research, Education, and Policy, Boston, MA

    Investigational Drug Services (Hem/Onc)

    Caroline Harvey, RPh
    Research Pharmacy Manager
    Education: Northeastern University, Boston, MA

    Inpatient Palliative Care Consult (PMPC)

    Bridget Fowler Scullion, PharmD, BCOP
    Clinical Pharmacy Manager
    Education: St. Louis College of Pharmacy
    PGY-2 Training: University of Maryland, School of Pharmacy, Baltimore, MD

    Medical Oncology (Hem/Onc)

    Andrew Skirvin, BS, PharmD, BCOP
    Associate Clinical Professor, Northeastern University, Hematology/Oncology Clinical Pharmacist
    Education: University of Texas Health Science Center (PharmD) and Oregon State University (BS)
    PGY-2 Training: Audie L. Murphy Memorial VA Hospital, San Antonio, TX

    Medication Safety (Hem/Onc)

    Audrea Szabatura, PharmD, BCOP
    Medication Safety Officer
    Education: University of Connecticut
    PGY-1 Training: Thomas Jefferson University Hospital, Philadelphia, PA
    PGY-2 Training: The Johns Hopkins Hospital, Baltimore, MD

    Inpatient Palliative Care Unit (Hem/Onc and PMPC)

    Victor Phantumvanit, PharmD, BCPs, BCOP
    Clinical Pharmacy Specialist
    Education: University of Maryland, School of Pharmacy, Baltimore, MD
    PGY-1 Training: Central Washington Hospital, Wenatchee, WA
    PGY-2 Training: Dana-Farber Cancer Institute, Boston, MA

    Outpatient Dispensing (PMPC)

    Phuong Nguyen, PharmD
    Outpatient Pharmacy Manager
    Education: Massachusetts College of Pharmacy and Health Sciences, Boston, MA

    Pediatrics (Hem/Onc)

    Theresa LeFrancois, PharmD, BCOP
    Pediatric Oncology Clinical Pharmacist
    Education: Massachusetts College of Pharmacy and Health Sciences, Boston, MA

  • Current and Past Residents

    Current Residents

    2016-2017

    Hematology/ Oncology

    Huong (Heather) Truong, PharmD
    PGY-1 Training: Yale New Haven Health System, New Haven, CT
    Education: University of Connecticut School of Pharmacy
    huongl_truong@dfci.harvard.edu

    Mary Nauffal, PharmD
    PGY-1 Training: Brigham and Women’s Hospital, Boston, MA
    Education: Lebanese American University, Beirut, Lebanon
    mary_nauffal@dfci.harvard.edu

    Pain Management/Palliative Care

    Benjamin S. Kematick, PharmD
    PGY-1 Training: University at Buffalo/Mobile Pharmacy Solutions
    Education: University at Buffalo, Buffalo, NY
    benjamins_kematick@dfci.harvard.edu

    Past Residents

    2015-2016

    Jacob Barker, PharmD
    PGY-1 Training: University of Michigan Health System, Ann Arbor, MI
    Education: University of New England School of Pharmacy, Portland, ME
    Current Position: Clinical Oncology Pharmacist, Roswell Park Cancer Institute, Buffalo, NY

    Sydney Smith, PharmD
    PGY-1 Training: Cleveland Clinic, Cleveland, OH
    Education: Roseman University of Health Sciences, Henderson, NV
    Current Position: Hematology/Oncology Clinical Pharmacist, Seattle Cancer Care Alliance, Seattle, WA

    2014-2015

    Doug Hackenyos, PharmD
    PGY-1 Training: Tufts Medical Center, Boston, MA
    Education: MCPHS University, Worcester, MA
    Current Position: Clinical Pharmacy Specialist, Tufts New England Medical Center

    Cynthia Herrera, PharmD
    PGY-1 Training: Northwestern Memorial Hospital, Chicago, IL
    Education: Purdue University College of Pharmacy, West Lafayette, IN
    Current Position: Hematology/Oncology Clinical Pharmacist, Northwestern Medicine, Chicago, IL

    2013-2014

    Laura Perry, PharmD
    PGY-1 Training: Dartmouth-Hitchcock Medical Center, Lebanon, NH
    Education: Massachusetts College of Pharmacy and Health Sciences, Boston, MA
    Current Position: Clinical Dispensing Pharmacist, South Shore Hospital, Weymouth, MA

    Taylor Butler, PharmD
    PGY-1 Training: Blout Memorial Hospital, Martville, TN
    Education: University of Tennessee Health Science Center, Memphis and Knoxville, TN
    Current Position: Clinical Pharmacist, Veterans Affairs Hospital, Nashville, TN

    2012-2013

    Amanda Dietzek, PharmD
    PGY-1 Training: Einstein Medical Center, Philadelphia, PA
    Education: Northeastern University, Boston, MA
    Current Position: Oncology Clinical Pharmacy Manager, Einstein at Center One Pharmacy, Philadelphia, PA

    Kelly Connelly, PharmD
    PGY-1 Training: Mount Sinai Medical Center, New York, NY
    Education: Duquesne University, Mylan School of Pharmacy, Pittsburgh, PA
    Current Position: Clinical Pharmacy Specialist, Johns Hopkins Hospital, Baltimore, MD

    2011-2012

    Kelley Carlstrom, PharmD, BCOP
    PGY-1 Training: Beth Israel Deaconess Medical Center, Boston, MA
    Education: University of Colorado, Denver College of Pharmacy, Denver, CO
    Current Position: Oncology Clinical Pharmacy Specialist, Cleveland Clinic, Cleveland, OH

    2010-2011

    Meredith W. H. Higley, PharmD, BCPS, BCOP
    PGY-1 Training: Parkview Health, Fort Wayne, IN
    Education: Massachusetts College of Pharmacy and Health Sciences, Boston, MA
    Current Position: Coordinator, Oncology Pharmacy Services, Berkshire Medical Center, Pittsfield, MA

    2009-2010

    Houry Leblebjian, PharmD, BCOP
    PGY-1 Training: UMass Memorial Medical Center, Worcester, MA
    Education: Lebanese American University, West Beirut, Lebanon
    Current Position: Clinical Pharmacy Specialist, Dana-Farber Cancer Institute, Boston, MA

    2008-2009

    Jian Ni, PharmD
    PGY-1 Training: West Virginia University Hospital, Morgantown, WV
    Education: Massachusetts College of Pharmacy and Health Sciences, Boston, MA
    Current Position: Hematology/Oncology Pharmacist, Brigham and Women's Hospital, Boston, MA

    2007-2008

    Delila Katz, PharmD, BCOP
    PGY-1 Training: Boston Medical Center, Boston, MA
    Current Position: Clinical Pharmacy Specialist, Palliative Care Oncology, UMass Memorial Medical Center, Worcester, MA

    2006-2007

    Victor Phantumvanit, PharmD, BCPS, BCOP
    PGY-1 Training: Central Washington Hospital, Wenatchee, WA
    Education: University of Maryland, School of Pharmacy
    Current Position: Clinical Pharmacy Specialist, Dana-Farber Cancer Institute, Boston, MA

    2005-2006

    Gayle Blouin, PharmD, BCOP
    Education: Massachusetts College of Pharmacy and Health Sciences, Boston, MA
    Current Position: Clinical Lead Pharmacist Ambulatory Oncology, Massachusetts General Hospital, Boston, MA

  • Applying for the Pharmacy Residency

    Eligibility

    PharmD degree and ASHP-accredited PGY-1 pharmacy residency required, with experience in respective specialty preferred. Candidate must also be eligible for licensure in the Commonwealth of Massachusetts.

    Application procedure

    Please submit your application through PhORCAS (Pharmacy Online Residency Centralized Application Service) — portal.phorcas.org — including:

    • Letter of intent
    • Curriculum vitae
    • Three letters of recommendation

    Deadline for applying: Refer to PhORCAS
    Residency start date: First week in July